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Metal Toxicity in the Central Nervous
System
by Thomas W. Clarkson*
The nervous system is the principal target for a number ofmetals. Inorganic compounds ofaluminum,
arsenic, lead, lithium, manganese, mercury, and thallium are well known for their neurological and
behavioral effectsinhumans. Thealkylderivatives ofcertainmetals-lead, mercuryandtin-arespecially
neurotoxic. Concern over human exposure and in some cases, outbreaks of poisoning, have stimulated
research into the toxic action ofthese metals.
Anumberofinterestinghypotheses havebeenproposedforthemechanismofleadtoxicityonthenervous
system. Lead is known to be apotent inhibitor ofhemesynthesis. Areduction in heme-containing enzymes
could compromise energy metabolism. Lead may affect brain function by interference with neurotrans-
mitters such as -y-amino-isobutyric acid. There is mounting evidence that lead interferes with membrane
transport and binding ofcalcium ions.
Methylmercury produces focal damage to specific areas in the adultbrain. One hypothesis proposes that
certain cells are susceptible because they cannot repair the initial damage to the protein sythesis ma-
chinery. The developing nervous system is especially susceptible todamage by methylmercury. It has been
discovered that microtubules are destroyed by this form of mercury and this effect may explain the
inhibition ofcell division and cell migration, processes that occur only in the developmental stages. These
and other hypotheses will stimulate considerable experimental challenges in the future.
Introduction
Metals are among the most ancient poisons known to
man. Mercury, named quicksilver by Aristotle, was de-
scribed by Pliny as an occupational scourge to miners
in Spain. Only criminals and slaves were employed in
the notorious Almaden mines (1). Lead exposure ofthe
ruling classes has been identified as a major cause for
the decline ofthe Roman empire (2).
The nervous system is the principal target for many
toxic metals. Mercury and lead will be discussed in de-
tail. Aluminum has been implicted in senile dementia in
dialysis patients (3), arsenic is well known to produce
peripheral neuropathies (4), manganese damages spe-
cific centers in the brain to produce symptoms remark-
ably similar to Parkinson's disease (5), thallium wreaks
havoc on the nervous system by mimicking potassium
(6), and lithium has such remarkable effects that it is
used to this day in the treatment ofchronic depression
(7). The most severe damage is produced by organo-
metallic forms such as methylmercury (8), tetramethyl
lead (9), and tin (10).
Lead and Mercury
Historical Background
Time does not permit a discussion of all these metals.
Instead, lead and mercury havebeenselectedfor abrief
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review. In the 1960s, lead was emerging into a major
public health problem. Ingestion ofpaint chips in inner
city homes had caused, by the 1950s, many cases of
severe encephalopathy, often having a fatal outcome.
The survivors suffered permanent brain damage (11).
Subsequently it was discovered that the exposure to
lead was more widespread and pervasive. Lead-con-
taining dust both within and outside the home was ele-
vating children's blood lead to toxic levels. The source
was not only leaded paint but industrial emissions. We
began to suspect leaded gasoline. More subtle effects
were detected in the central nervous system, including
behavioral disorders and intelligence deficits (12).
The discharge ofmethylmercury into an ocean bay in
Japan in the 1950s lead to a mass health disaster (13).
The bay gave a name to a new clinical syndrome-
MinimataDisease. Fromtheoriginal 120casesofsevere
brain damage,'there are now identified thousands of
follow-up cases. In the 1960s it was realized that meth-
ylmercury couldbe producedwithoutthe helpofhuman
industry. JensenandAineJernelov (14) discoveredthat
microorganisms in sediments of lakes and rivers could
methylate inorganic mercury, starting a process of
bioaccumulation'in aquaticfood chainsleadingtohuman
intake from fish. The report of high concentrations of
methylmercury in many species ofedible fish in Canada
and the U.S. lead to a near panic reaction. Large areas
of fresh water for sports and commercial fishing were
shut down, and even some species of ocean fish were
banned from interstate commerce (15).T. W. CLARKSON
In such asituation where we knew little about human
dose-response relationships or mechanisms of action,
the National Institute of Environmental Health Sci-
ences encouraged and supported a broad program of
research into how these metals damaged the nervous
system. This is a briefreport of some ofthis research.
Studies on Mechanisms ofAction
Like most other toxic metals, lead and mercury exist
as cations, and as such, can react with most ligands
present in living cells. These include such common li-
gands as SH, phosphate, amino, and carboxyl. Thus
they have the potential to inhibit enzymes, disrupt cell
membranes, damage structural proteins, and affect the
genetic code in nucleic acids. The very ubiquity of po-
tential targets presents a great challenge to investi-
gations on mechanisms of action.
Investigations on metal action have followed devel-
opments in biology. Studies of heavy metal action on
enzymes in the 1920s paralleled the current interest of
biochemistry at that time period in metabolic pathways
(16). Indeed, metals were found to be useful in the iso-
lation and purification ofenzymes. Studies onthe mech-
anism ofaction ofarsenicals in World War II ultimately
lead to the discovery of a-lipoic acid, the essential co-
factor of pyruvate dehydrogenase (17).
The 1950s saw dramatic developments in membrane
transport work. This in turn lead to the discovery that
certaintransport processes werehighlysensitive to cer-
tain metals. The uranyl ion was used by Rothstein as a
powerful tool to elucidate the membrane binding sites
involved inglucose transport (16). He proposed theidea
ofgeographical selectivity ofmetals (18). Metals would
first react with surface ligands on the plasma mem-
brane. Some surface sites are involved inglucose trans-
port. As the metal moved into the membrane itself, the
permeability was increased. Once inside the membrane,
a number of intracellular processes were affected.
The 1960s and 1970s saw developments in studies of
intracellular particles, protein synthesis, nucleic acid
metabolism, and most recently, calcium and the cyto-
skeleton. In the case oflead and methylmercury, these
biological advances led to progress in our knowledge of
the toxicology of these metals.
In discussing some ideas on the mechanism of action




the clinical signs and symptoms. The assumption is that
some day this will be possible. In the meantime, basic
mechanisms ofaction can still give insight into how cell
function is affected and can give plausible explanations
for many of the effects seen at the whole animal and
epidemiological levels.
Lead-Mechanisms ofAction
The effects of lead on the central nervous system in
children range from acute encephalopathy to a chronic,
subtle change in behavior and cognition. Cerebrovas-
cular damage is probably involved in acute high doses.
The basic lesions underlying the chronic effects are a
matter ofgreat interest and research activity.
Several fascinating theories about the mechanism of
lead-induced damage have been proposed. Lead is well
knowntodisruptheme synthesis (11). The lossofheme-
containingenzymesshouldaffectmitochondrialfunction
(19), producing adverse effects on energy metabolism.
The cells of the blood-brain barrier are especially rich
in mitochondria, making the blood-brain barrier sus-
ceptible to lead poisoning (20).
Lead may affect neurotransmission by interference
withneurotransmitters (21). Infact, aminolevulinic acid
(ALA), produced as a result of lead action on heme
synthesis, has a similar chemical structure to the neu-
rotransmitter y-amino-isobutyric acid (GABA). Action
on the GABA system might produce signs ofneurotox-
icity similar to those seen in severe lead poisoning (22).
ALA may bind to GABA receptors (23). Action oflead
is also a possibility on acetylcholine and catecholamine
systems.
Some of these effects may be secondary to a more
primary point of attack by lead. In this respect there
is now great interest in the effects of lead on calcium
metabolism and transport (24). Kostial and Vouk (25)
were among the first to demonstrate the importance of
lead-calcium interactions (Fig. 1). Using the perfused
cervicalganglionofthecat, theydemonstratedthatlead
can inhibit the release ofacetylcholine. The effect per-
sisted onwashingwith lead-free Locke solutionbutwas
dramatically reversed when the concentration of cal-















FIGURE 1. The antagonism ofcalcium on the effects oflead on ace-
tylcholine release from the cat cervical ganglion in vitro. Lead
inhibits acetylcholine release (second column). The effect persists
when the preparation is washed with lead-free Lockes solution
(column 3), but is dramatically reversed when the calcium con-
centration is increased. From Kostial and Vouk (25).
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effects could be produced with lead concentrations as
low as those expected to be present in brains of lead
poisoned animals.
Since the publication ofthis report, considerable ad-
vances have been made in our knowledge ofthe role of
calcium in the nervous system (Fig. 2). Calcium enters
the presynaptic terminal via the calcium channel in re-
sponse to the arrival of a wave of depolarization (24).
Inside the cell, calcium activates calmodulin, leading to
the fusion of acetylcholine vesicles with the plasma
membrane andthereleaseofacetylcholine. Thereisnow
mounting evidence that lead competitively inhibits cal-
icum entry. The findings of Kostial and Vouk can be
explained by the action of lead on this channel. More
recently, Cooper and associates at Cincinnati (26) have
elegantly demonstrated this competition. They meas-
ured the magnitude of the endplate potential that re-
sults from calcium entry into the cell and were able to
showcompetitiveinhibitionbyleadandcalculate aLine-
weaver-Burke inhibitory constant in the micromolar
range.
Atchison and Narahashi (27) have provided evidence
that lead can produce intracellular effects. Miniature
endplate potentials (MEPP) are produced by the spon-
taneous and continuous release of packages of acetyl-
choline into the synaptic cleft. In the presence oflead,
MEPPs are increased. This probably results from entry
of lead via the calcium channel and interference with
those processes regulating intracellular calcium such as
mitochondrial uptake.
Indeed, mitochondrial uptake of lead has been ele-
gantly demonstrated by Silbergeld and Goldstein in
electron probe measurements in endothelial cells of
brain capillaries (28). Action of lead on mitochondrial
respiration mayunderlie the damage that lead is known
to produce to the blood-brain barrier. Goyer first pro-
posed a mitochondrial effect of lead to explain damage
to kidney cells that, like the endothelial cells of the
Ca++
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FaIGURE 2. A schematic representation ofthe role of calcium in the
presynaptic nerve terminal. For further details, see text.
blood-brain barrier, require a copious supply of ATP
(11).
A discussion ofthe mechanism oflead toxicity would
be incomplete without mention of what appears to be
an important cellular protective process. In studies on
the renal deposition oflead, Goyer et al. (29) had noted
the appearance ofelectron dense inclusion bodies in the
cell nucleus. These inclusion bodies contained high con-
centrations of lead and an acidic protein (30). Protein
synthesis was required for their formation (31). Ac-
cordingto McLachlin etal. (31), lead combines firstwith
soluble proteins in the cytosol, followed by aggregation
of the lead-protein complex to form visible inclusion
bodies. The latter aretransported into and accumulated
in the cell nucleus. The formation of inclusion bodies
protects the cell, and particularly the mitochondria,
from the toxic effects of lead (11,32).
More recently, Holtzman et al. (33) have shown that
intranuclear inclusionbodies in astrocytes protectbrain
cells from mitochondrial damage. Indeed, the suscep-
tibility ofthe very young animal may be due to the fact
that intranuclear bodies cannot be induced at an early
age. In line with Holtzman's ideas, Egle and Skelton
(34) found that the protein associated with these bodies
was not detectable in younger animals but its presence
in tissues increased dramatically with age.
Mercury-Mechanisms of Action
The onset of clinical signs and symptoms is shown in
Figure 3 in a victim of the outbreak in Iraq in 1972.
Paresthesia is usually first to appear. Later this is fol-
lowed by more serious effects such as ataxia and other
signs of loss of coordination such as slurred speech.
Constriction of the visual field frequently occurs as a
late sequelae. All these signs and symptoms arise from
damage to the nervous system, particularly the central
nervous system. In fact, damage is remarkably selec-
tive, being limited to specific focal areas such as the
granule cells of the cerebellum and the neurons in the
interstices ofthe visual cortex (35).
Suchselectiveactionissurprisinginviewofthechem-
ical properties of methylmercury. The mercury cation
reacts rapidly and with high affinity to SH groups (36).
When present at sufficient concentrations, it willinhibit
anySH-containing enzyme. Furthermore, itreadilydis-
tributes to all tissues in the body, and the brain has
concentrations no higher than other tissues (37).
The first clue to its selective actionwas the discovery
that methylmercury inhibited protein synthesis in the
brain (38). Protein synthesis was affected in the latent
period well before clinical signs appeared. Syversen
studied this effect in three different neuronal cell types
(39). Rats were treated with a low dose ofmethylmer-
cury and sacrificed at various times. Cells were har-
vested from different parts of the brain and tested for
protein synthesis. Protein synthesis was inhibited in all
three cell types. In the two nontarget cells (neurons
from the cerebrum and Purkinje cells that are usually
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FIGURE 3. The onset of clinical signs of symptoms in a victim of methylmercury poisoning in the Iraq outbreak of 1971-72. The solid line
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FIGURE 4. A comparison of the structure of methionine with the
methylmercury complexes with cystein and homocysteine.
place. In the granule cell, which is a target cell (usually
damaged in methylmercury poisoning), no recovery
took place. Thus, selective action on the brain may be
due tothefact that certain cells are susceptible because
they cannot repair damage from methylnercury. The
initialdamageisnonselective, consistentwiththechem-
ical properties ofmethylmercury.
Verity and hiscolleagues (40) haveidentified the step
in protein synthesis most sensitive to methylmercury.
The peptide elongation can be affected at high levels of
methylmercury, but the first stage of synthesis asso-
ciated with transfer RNA may be the most sensitive.
There is no selective inhibition offormation of any spe-
cial proteins or group of proteins. Cheung and Verity
(40) suggested that methylmercury was inhibiting one
or more ofthe amino acyl tRNA synthetase enzymes.
The first amino acid to start the polypeptide chain is
alwaysmethionine. Perhapsitmaybeacoincidencethat
methylmercury may enter the brain as an amino acid
complex structurally similarto methionine. It had been
knownforsometimethatcertainthiol-containingamino
acidsacceleratetransportacrosstheblood-brainbarrier
andthatlargeneutral aminoacids caninhibit entryinto
the brain (41-43). The process appears to be stereo-
specific, as the D, but not L, enantiomorph ofthe cys-
teine methylmercury complex enters the brain (43).
Thus, Hiriyama suggested that "the blood-brain trans-
port system (foramino acids)" participates in some way
inthe penetrationofmethylmercury intothebrain (43).
Recently, Aschner and Clarkson (44) suggested that
transport of methylmercury as the cysteine complex
may be due to its structural similarity to methionine
(Fig. 4). Methionine shares withthe otherlargeneutral
amino acids a common carrier in the membranes ofthe
endothelial cells of the brain capilles (45,46). Con-
sistent with this suggestion, Aschner and Clarkson re-
portthat methionine alsoinhibited the entryofthe cys-
teine complex intothebrain. Thus the possibility arises
thatmethylmercury not only enters the brain as a com-
plex structurally similarto methionine but may exist in
this form until it penetrates to the ribosomes and the
site ofiniitiation ofprotein synthesis.
Asinthe case oflead, thedevelopingnervous system
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FIGURE 5. The effects ofmethylmercury on cell divisioninthe dev-
loping brain. Two-day-old mice were given 4 or 8 mg Hg/kg as
methylmercury chloride perosand sacrificed 24hrlater. Thetotal
number of mitotic figures in the external granule layer of the
cerebellar cortexwere recorded in matched sections and classified
as early or late. Data are plotted as the percentage oflate mitotic
figures (anaphase and telophase). Bars are the standard errors
(n = 10-15). Adapted from (54).
is the most susceptible stage of the life cycle to meth-
ylmercury (47,48). Evidence from human autopsies in-
dicatederangement ofbrainstructure andsmallerbrain
size without selective damage as seen in the adult (49).
Onereasonforthishighersusceptibilityisthatmercury
affects processes unique to the developing nervous sys-
tem, namely cell migration and cell division.
Once more, advances inbasicbiology, in this case the
structure of the cytoskeleton, has led to insight into
molecular mechanisms. Methylmercury leads to rapid
depolymerization ofmicrotubules (50). Cells exposed to
low concentrations rapidly lost microtubule structures
(51,52). Two protein monomers, a and P tubulin, ag-
gregate to form microtubules. Formation ofthe tubule
takes place at one end of the forming tubule, whereas
the tubule dissociates at the other end (53). Methyl-
mercury reacts with the SH groups on tubulin mono-
mers to disrupt the assembly process. The dissociation
process continues, thus leading to depolymerization of
the tubule.
As microtubules are essential for cell division (they
are the main component ofthe mitotic spindle), effects
on cell division can be understood. Effects on the di-
vision of granule cells in the developing cerebellum of
the mouse are illustrated in Figure 5. A single dose of
8 mg/kg to 2-day-old mice inhibits cell division in both
sexes, whereas the 4 mg/kg dose affects cell division
only in male animals. It is ofinterest that this sex dif-
ferenceconfirmsfindingsinrecentepidemiologicalstud-
ies in Canada (55). Furthermore, the 4 mg/kg dose pro-
ducesthelowestbrainlevelsofmethylmercuryatwhich
any effects have been seen.
Conclusion
In conclusion, our knowledge of the mechanisms of
action of lead and mercury develops in parallel with,
and in most cases as a result of, advances in basic bi-
ology. Basic biology has now realized an excitingphase
where specific hypotheses have been advanced at a mo-
lecular level. These hypotheses should lead to consid-
erable experimental challenge in the future.
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